Image source
Cresco Labs Inc. (CRLBF), a constituent in the munKNEE American Cannabis MSO Stocks Index, has released its financial results for the first quarter (Q1) ended March 31, 2024, today, as follows:
Q1 Financial Highlights
(The information below compares Q1 2024 with Q4 2023 and all figures are in U.S. dollars.)
- as a % of Net Revenue: DOWN to 51.5% from 53.0%
- as a % of Net Revenue: DOWN to 28.1% from 29.0%
- as a % of Revenue: DOWN to 28.9% from 29.1%
Cresco’s reported Q1 profit/loss as a percentage of quarterly revenue compared with the other 6 constituents in the munKNEE American Cannabis MSO Stocks Index, was, in descending order, as follows:
- Q1 profit as a % of Revenue: 11.3%
- Q1 loss as a % of Revenue: (1.1)%
- Q1 loss as a % of Revenue: (2.2)%
- Q1 loss as a % of Revenue: (7.7)%
- Q1 loss as a % of Revenue: (16.9)%
- Q1 loss as a % of Revenue: (142.5)%
- Q1 loss as a % of Revenue: (184.9)%
Q1 Operating Highlights
Stock Performance
Despite the poor Q1 financial report Cresco’s stock price is UP 2.5% as of mid-day but is still DOWN 1.9% from last Friday albeit UP 52.6% YTD.More By This Author:Organigram Q2 Financial Metrics Mixed
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
Cronos Q1 Financial Metrics Show Improvement; Stock Climbs 3%
